We describe preliminary studies of the pharmacokinetics, biodistribution, and excretion of an oligodeoxynucleotide phosphorothioate ([SJoligonucleotide) in mice. After either intravenous or intraperitoneal administration of a single dose (30 mg/kg of body weight), at each internucleotide linkage) was found in most of the tissues for up to 48 hr. About 30% of the dose was excreted in urine within 24 hr, irrespective of the mode of adminitration; the excreted [Sloligonucleotide was found to be extensively de-graded. In plasma, stomach, heart, and intestine, the [Sloligonucleotide was degraded by only 15%, whereas in the kidney and liver degradation was about 50% in 48 hr. The surprising observation was made that chain length extension of administered [Sioligonucleotide occurred in kidney, liver, and intestine. These results provide an initial definition of parameters for the pharmaceutical development of antisense oligonucleotides.
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Previous studies demonstrated that replication of human immunodeficiency virus (HIV) could be inhibited by normal phosphodiester oligonucleotides complementary to HIV RNA (1) (2) (3) . However, the relatively short half-life of normal oligonucleotides in serum and in cells, due to the presence of nucleases, limits their potential usefulness in vivo (4) . To overcome this limitation, oligonucleotides with modified internucleoside phosphate backbones, such as methylphosphonates (5, 6) , phosphorothioates, and several phosphoramidate analogues (3, (7) (8) (9) (10) (11) (12) , have been studied. These analogues of oligodeoxynucleotides are more resistant to nucleases than their unmodified counterparts, and they should therefore exhibit longer survival times in vivo. Oligodeoxynucleotide phosphorothioates ( Milligen/Biosearch, Novato, CA) using H-phosphonate chemistry on controlled-pore glass, followed by oxidation with 0.2 M sulfur in carbon disulfide/pyridine/triethylamine (9:9:1, vol/vol). The syntheses were carried out on a 5-to 10-,umol scale. The [S]oligonucleotides were purified by lowpressure ion-exchange chromatography (DEAE-cellulose, DE-52; Whatman) followed by reverse-phase chromatography (C18) and finally dialysis (10) . The [S]oligonucleotide synthesized for the present study had the base sequence 5'-ACA-CCC-AAT-TCT-GAA-AAT-GG-3', which is complementary to the HIV tat splice acceptor site (nucleotides 5349-5368).
3"S-Labeled [S] Oligonucleotide. Five milligrams of oligodeoxynucleoside H-phosphonate (20-mer, same sequence as above) bound to controlled-pore glass was oxidized with a mixture of 35S8 (5 mCi, 1 Ci/mg, Amersham; 1 Ci = 37 GBq) in 40 A.l of carbon disulfide/pyridine/triethylamine (9:9:1).
After 30 min, 100 p.l of 7% (wt/vol) unlabeled S8 in the same solvent mixture was added and the reaction continued for another 60 min. The solution was removed and the support was washed with carbon disulfide (3 x 500 pl) and with acetonitrile (3 x 700 ,u). The product was deprotected in concentrated ammonia (55°C, 14 hr), evaporated, and desalted with a Sep-Pak C18 column (Waters). The resultant product was purified by 20%o polyacrylamide gel/7 M urea electrophoresis. 6 hr, 9 hr, 12 hr, 24 hr, and 48 hr following intravenous administration, one test animal was sacrificed and blood and organs were removed. At 1, 2, 3, 6, 9, 12, 24, and 48 hr following intraperitoneal administration one test animal was sacrificed and blood and organs were removed for determination of total radioactivity. The organs were homogenized (in deionized water, 1:10 dilution) prior to the determination of total radioactivity. The homogenates were kept at -20°C until extractions.
The urine and feces were collected in metabolism cages for total radioactivity determination from each of three animals following both intravenous and intraperitoneal routes of administration. Samples were collected from 0 to 6 hr, 6 to 12 hr, and 12 to 24 hr.
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NaCI/20 mM Tris HCI, pH 7.6/10 mM EDTA) for 2 hr at 370C. The samples were then extracted twice with phenol/ chloroform (1:1, vol/vol) and once with chloroform. After ethanol precipitation, the oligonucleotides were analyzed by electrophoresis in 20% polyacrylamide gels containing 7 M urea. The gels were fixed in 10% acetic acid/10%o methanol solution before autoradiography.
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i. p. (Fig. 4) , although obviously decreasing in total amount (see Fig. 3 ). The same overall result was obtained with [Sloligonucleotide recovered from small and large intestine (Fig. 5) . In kidney (Fig. 6) (Fig. 7) .
The gel electrophoretic analysis of the [S]oligonucleotide recovered from kidney displayed the progressive appearance at 6 hr of two bands of slower mobility than the initially administered oligonucleotide (Fig. 6 (Fig. 5 ). In the case of large intestine (Fig. 5 Upper), at only 5 min postinjection there was a series of bands that migrated behind the initial [Sloligonucleotide. These bands appeared to represent an oligomeric series. There were also some very high molecular weight bands that barely entered the gel (see 30-min, 1-hr, 3-hr, and 9-hr lanes). In small intestine (Fig. 5 Lower) these high molecular weight bands were more evident, whereas bands of intermediate mobility were less apparent. In both large and small intestine, there was no evidence of bands migrating immediately behind the initial oligonucleotide as was observed in kidney (Fig. 6) In kidney and liver, new bands appeared on gel electrophoresis at the 1-hr time point, moving more slowly than the 20-mer band (Fig. 6) The presence ofthe slower-mobility bands in both kidney and liver was observed with both intraperitoneal and intravenous routes of administration.
In the case of oligonucleotide extracted from large and small intestine, following either intravenous or intraperitoneal administration, a series of bands moving more slowly than 20-mer was observed (Fig. 5) . It is possible that [S]oligonucleotide was being degraded and that nucleoside [[35S] thio]phosphate was being incorporated into endogenous nucleic acids. However, it is not evident that this would lead to the series of discrete bands observed. A more likely explanation is ligation and/or extension of the oligonucleotide. Also noted in both small and large intestine was the presence of high molecular weight bands (Fig. 5) 
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The oligonucleotide analogue appears to be degraded mostly by exonucleases. In some organs, such as kidney, liver, and intestine, it is extended in length.
